CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
1.010
-0.040 (-3.81%)
Nov 4, 2024, 4:00 PM EST - Market closed
CytomX Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 79 | 104 | 106 | 283 | 303 | 378 | |
Market Cap Growth | -16.69% | -1.80% | -62.58% | -6.69% | -19.81% | -44.44% | |
Enterprise Value | -47 | -75 | -70 | 69 | 7 | 80 | |
Last Close Price | 1.01 | 1.55 | 1.60 | 4.33 | 6.55 | 8.31 | |
PE Ratio | 7.50 | -201.06 | -1.06 | -2.40 | -4.66 | -2.84 | |
PS Ratio | 0.70 | 1.03 | 1.99 | 7.57 | 4.42 | 14.03 | |
PB Ratio | -3.04 | -2.19 | -1.23 | -615.53 | -38.95 | 7.39 | |
P/FCF Ratio | -1.10 | -1.83 | -0.94 | -2.34 | 102.63 | -2.62 | |
P/OCF Ratio | -1.11 | -1.85 | -0.95 | -2.37 | 57.57 | -2.69 | |
EV/Sales Ratio | -0.35 | -0.74 | -1.31 | 1.84 | 0.11 | 2.98 | |
EV/EBITDA Ratio | -5.56 | 17.46 | 0.76 | -0.61 | -0.09 | -0.58 | |
EV/EBIT Ratio | -7.40 | 11.60 | 0.74 | -0.59 | -0.09 | -0.57 | |
EV/FCF Ratio | 0.49 | 1.32 | 0.62 | -0.57 | 2.48 | -0.56 | |
Debt / Equity Ratio | -0.38 | -0.29 | -0.21 | -47.22 | -3.20 | 0.54 | |
Debt / FCF Ratio | -0.14 | -0.25 | -0.16 | -0.18 | 8.43 | -0.19 | |
Asset Turnover | 0.65 | 0.44 | 0.18 | 0.11 | 0.20 | 0.07 | |
Quick Ratio | 0.98 | 1.14 | 1.50 | 3.93 | 4.65 | 3.46 | |
Current Ratio | 1.00 | 1.17 | 1.55 | 3.98 | 4.76 | 3.54 | |
Return on Equity (ROE) | - | - | - | - | -299.13% | -145.96% | |
Return on Assets (ROA) | 1.94% | -1.75% | -19.54% | -20.78% | -14.38% | -22.15% | |
Return on Capital (ROIC) | - | - | - | -378.62% | -104.99% | -84.35% | |
Earnings Yield | 14.05% | -0.55% | -93.93% | -41.01% | -21.41% | -35.18% | |
FCF Yield | -109.36% | -54.78% | -106.42% | -42.70% | 0.97% | -38.13% | |
Buyback Yield / Dilution | -24.87% | -12.27% | -2.48% | -39.01% | -1.79% | -8.81% | |
Total Shareholder Return | -24.87% | -12.27% | -2.48% | -39.01% | -1.79% | -8.81% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.